PULMATRIX, INC. Interest Expense
PULMATRIX, INC. (PULM) reported Interest Expense of $106.00 thousand for the 3-month period ending 2018-12-31, per its 10-Q filed 2019-05-15.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2020-03-26
- PULMATRIX, INC. interest expense for the quarter ending 2018-12-31 was $106.00K, a 19.08% decline year-over-year.
- PULMATRIX, INC. interest expense for the quarter ending 2018-09-30 was $0.00, a 100.00% decline year-over-year.
- PULMATRIX, INC. interest expense for the quarter ending 2018-06-30 was $80.00K, a 53.49% decline year-over-year.
- PULMATRIX, INC. interest expense for the quarter ending 2018-03-31 was $106.00K, a 43.32% decline year-over-year.
- PULMATRIX, INC. interest expense for fiscal 2018 was $186.00K, a 71.07% decline from fiscal 2017.
- PULMATRIX, INC. interest expense for fiscal 2017 was $643.00K, a 27.01% decline from fiscal 2016.
- PULMATRIX, INC. interest expense for fiscal 2016 was $881.00K, a 7.56% decline from fiscal 2015.
- PULMATRIX, INC. interest expense for fiscal 2015 was $953.00K, a 93.76% decline from fiscal 2014.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2018-12-31 | $106.00K 10-Q · filed 2019-05-15 | $106.00K derived: sum of 2 quarters · filed 2019-11-01 | $186.00K derived: sum of 3 quarters · filed 2019-11-01 | $186.00K 10-K · filed 2020-03-26 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-01 | $80.00K derived: sum of 2 quarters · filed 2019-11-01 | $186.00K 10-Q · filed 2019-11-01 | $317.00K derived: sum of 4 quarters · filed 2019-11-01 |
| 2018-06-30 | $80.00K 10-Q · filed 2019-08-05 | $186.00K 10-Q · filed 2019-08-05 | $317.00K derived: sum of 3 quarters · filed 2019-08-05 | $470.00K derived: sum of 4 quarters · filed 2019-08-05 |
| 2018-03-31 | $106.00K 10-Q · filed 2018-05-11 | $237.00K derived: sum of 2 quarters · filed 2019-02-19 | $390.00K derived: sum of 3 quarters · filed 2019-02-19 | $562.00K derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $284.00K derived: sum of 2 quarters · filed 2019-02-19 | $456.00K derived: sum of 3 quarters · filed 2019-02-19 | $643.00K 10-K · filed 2019-02-19 |
| 2017-09-30 | $153.00K 10-Q · filed 2018-11-14 | $325.00K derived: sum of 2 quarters · filed 2018-11-14 | $512.00K 10-Q · filed 2018-11-14 | $720.00K derived: sum of 4 quarters · filed 2018-11-14 |
| 2017-06-30 | $172.00K 10-Q · filed 2018-08-03 | $359.00K 10-Q · filed 2018-08-03 | $567.00K derived: sum of 3 quarters · filed 2018-08-03 | $792.00K derived: sum of 4 quarters · filed 2018-08-03 |
| 2017-03-31 | $187.00K 10-Q · filed 2018-05-11 | $395.00K derived: sum of 2 quarters · filed 2018-05-11 | $620.00K derived: sum of 3 quarters · filed 2018-05-11 | $844.00K derived: sum of 4 quarters · filed 2018-05-11 |
| 2016-12-31 | $208.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $433.00K derived: sum of 2 quarters · filed 2018-03-13 | $657.00K derived: sum of 3 quarters · filed 2018-03-13 | $881.00K 10-K · filed 2018-03-13 |
| 2016-09-30 | $225.00K 10-Q · filed 2017-11-09 | $449.00K derived: sum of 2 quarters · filed 2017-11-09 | $673.00K 10-Q · filed 2017-11-09 | $894.00K derived: sum of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | $224.00K 10-Q · filed 2017-08-04 | $448.00K 10-Q · filed 2017-08-04 | $669.00K derived: sum of 3 quarters · filed 2017-08-04 | $889.00K derived: sum of 4 quarters · filed 2017-08-04 |
| 2016-03-31 | $223.00K 10-Q · filed 2017-05-05 | $445.00K derived: sum of 2 quarters · filed 2017-05-05 | $665.00K derived: sum of 3 quarters · filed 2017-05-05 | $992.00K derived: sum of 4 quarters · filed 2017-05-05 |
| 2015-12-31 | $222.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $442.00K derived: sum of 2 quarters · filed 2017-03-10 | $769.00K derived: sum of 3 quarters · filed 2017-03-10 | $953.00K 10-K · filed 2017-03-10 |
| 2015-09-30 | $220.00K 10-Q · filed 2016-11-04 | $547.00K derived: sum of 2 quarters · filed 2016-11-04 | $731.00K 10-Q · filed 2016-11-04 | $1.25M derived: sum of 4 quarters · filed 2016-11-04 |
| 2015-06-30 | $327.00K 10-Q · filed 2016-08-04 | $511.00K 10-Q · filed 2016-08-04 | $1.03M derived: sum of 3 quarters · filed 2016-08-04 | $8.92M derived: sum of 4 quarters · filed 2016-08-04 |
| 2015-03-31 | $184.00K 10-Q · filed 2016-05-05 | $706.00K derived: sum of 2 quarters · filed 2016-05-05 | $8.59M derived: sum of 3 quarters · filed 2016-05-05 | $14.20M derived: sum of 4 quarters · filed 2016-05-05 |
| 2014-12-31 | $522.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10 | $8.41M derived: sum of 2 quarters · filed 2016-03-10 | $14.02M derived: sum of 3 quarters · filed 2016-03-10 | $15.28M 10-K · filed 2016-03-10 |
| 2014-09-30 | $7.88M 10-Q · filed 2015-11-12 | $13.50M derived: sum of 2 quarters · filed 2015-11-12 | $14.75M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $5.61M 10-Q · filed 2015-08-14 | $6.87M 10-Q · filed 2015-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |